1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow AriBio Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) AR1001, Placebo - Alzheimer Disease | Phase 3 | Active not recruiting | AriBio Co., Ltd. | 1535 | 2022-12-23 | 2026-10-14 |
Canada (1) · China (1) · Czechia (1) · Denmark (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Poland (1) · South Korea (1) · Spain (1) · United Kingdom (1) · United States (1)
James Rock (1) · Sharon Sha, MD, MS (1)